Unknown

Dataset Information

Targeting obesity-related dysfunction in hormonally driven cancers.


ABSTRACT: Obesity is a risk factor for at least 13 different types of cancer, many of which are hormonally driven, and is associated with increased cancer incidence and morbidity. Adult obesity rates are steadily increasing and a subsequent increase in cancer burden is anticipated. Obesity-related dysfunction can contribute to cancer pathogenesis and treatment resistance through various mechanisms, including those mediated by insulin, leptin, adipokine, and aromatase signalling pathways, particularly in women. Furthermore, adiposity-related changes can influence tumour vascularity and inflammation in the tumour microenvironment, which can support tumour development and growth. Trials investigating non-pharmacological approaches to target the mechanisms driving obesity-mediated cancer pathogenesis ar

SUBMITTER: Rubinstein MM 

PROVIDER: S-EPMC8368182 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature